Similar articles for PMID: 15505023

Year	Number of Results
1949	1
1950	1
1963	1
1967	2
1968	1
1972	1
1982	1
1983	1
1984	1
1991	1
1993	1
1996	3
1997	1
1999	2
2000	1
2001	4
2002	4
2003	7
2004	5
2005	3
2006	4
2007	6
2008	10
2009	4
2010	2
2011	1
2012	4
2013	3
2014	2
2015	3
2016	3
2017	2
2018	4
2020	4
2024	0

1

The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, Pogue J. Levy AP, et al. Diabetes Care. 2004 Nov;27(11):2767. doi: 10.2337/diacare.27.11.2767. Diabetes Care. 2004. PMID: 15505023 No abstract available.

2

The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes.

Blum S, Vardi M, Levy NS, Miller-Lotan R, Levy AP. Blum S, et al. Atherosclerosis. 2010 Jul;211(1):25-7. doi: 10.1016/j.atherosclerosis.2010.02.018. Epub 2010 Feb 21. Atherosclerosis. 2010. PMID: 20223458 Free PMC article. No abstract available.

3

Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease.

Levy AP. Levy AP. Isr Med Assoc J. 2004 May;6(5):308-10. Isr Med Assoc J. 2004. PMID: 15151377 Free article. Review. No abstract available.

4

Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.

Levy AP, Blum S. Levy AP, et al. Expert Rev Cardiovasc Ther. 2007 Nov;5(6):1105-11. doi: 10.1586/14779072.5.6.1105. Expert Rev Cardiovasc Ther. 2007. PMID: 18035926 Review.

5

The protean role of haptoglobin and haptoglobin genotypes on vascular complications in diabetes mellitus.

Dalan R, Liuh Ling G. Dalan R, et al. Eur J Prev Cardiol. 2018 Sep;25(14):1502-1519. doi: 10.1177/2047487318776829. Epub 2018 May 25. Eur J Prev Cardiol. 2018. PMID: 29799294 Review.

6

Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.

Vardi M, Blum S, Levy AP. Vardi M, et al. Eur J Intern Med. 2012 Oct;23(7):628-32. doi: 10.1016/j.ejim.2012.04.009. Epub 2012 May 14. Eur J Intern Med. 2012. PMID: 22939808 Free PMC article. Review.

7

Haptoglobin genotype and its role in diabetic cardiovascular disease.

Costacou T, Levy AP. Costacou T, et al. J Cardiovasc Transl Res. 2012 Aug;5(4):423-35. doi: 10.1007/s12265-012-9361-z. Epub 2012 Mar 24. J Cardiovasc Transl Res. 2012. PMID: 22447230 Free PMC article. Review.

8

Patient selection and vitamin E treatment in diabetes mellitus.

Goldenstein H, Levy NS, Lipener YT, Levy AP. Goldenstein H, et al. Expert Rev Cardiovasc Ther. 2013 Mar;11(3):319-26. doi: 10.1586/erc.12.187. Expert Rev Cardiovasc Ther. 2013. PMID: 23469912 Free PMC article. Review.

9

Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.

Hochberg I, Berinstein EM, Milman U, Shapira C, Levy AP. Hochberg I, et al. Curr Diab Rep. 2017 Jun;17(6):42. doi: 10.1007/s11892-017-0868-1. Curr Diab Rep. 2017. PMID: 28451949 Review.

10

Pharmacogenomic application of the haptoglobin genotype in the prevention of diabetic cardiovascular disease.

Blum S, Milman U, Shapira C, Levy AP. Blum S, et al. Pharmacogenomics. 2008 Aug;9(8):989-91. doi: 10.2217/14622416.9.8.989. Pharmacogenomics. 2008. PMID: 18681772 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

92 results

Results by year